Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2020
Pharma News, 2020
FDA approves ViiV's novel HIV treatment Rukobia
The US Food and Drug Administration (FDA) has approved ViiV Healthcare's novel attachment inhibitor Rukobia (fostemsavir) expanding treatment options for HIV.
A Common Asthma Drug Shows Promise as a Treatment for Alzheimer’s
A new study reveals that the asthma drug salbutamol may offer potential as a treatment for Alzheimer’s disease.
Granules Pharmaceuticals, Inc. issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
Granules Pharmaceuticals, Inc.
Tesla to Build Mobile RNA Microfactories for CureVac's COVID-19 Vaccine
Tesla, the electric car company founded and run by Elon Musk, is building mobile molecular printers to assist Germany’s CureVac in manufacturing its experimental COVID-19 vaccine.
China develops novel rabies vaccine
WUHAN, June 30 (Xinhua) -- A novel rabies vaccine for humans shows promise in preclinical testing, according to a new study published in the journal EBioMedicine.
Coronavirus damages the endocrine system
People with endocrine disorders may see their condition worsen as a result of COVID-19, according to a new review published in the Journal of the Endocrine Society.
Researchers develop a new ultrafast insulin
Researchers at Stanford University are developing a new insulin formulation that begins to take effect almost immediately upon injection, potentially working four times as fast as current commercial f...
US approves Bavencio for bladder cancer
EMD Serono, the biopharmaceutical business of Merck KGaA, and Pfizer today announced that the US Food and Drug Administration (FDA) has expanded use of Bavencio (avelumab) to include m...
Fujifilm pairs with Dr. Reddy's, Global Response Aid to make COVID-19 drug Avigan
Meeting global demand for a potential COVID-19 treatment is more than any one company can handle on its own.
China's Sinopharm unit completes new COVID-19 vaccine plant, doubles capacity
BEIJING (Reuters) - China National Biotec Group (CNBG) said on Wednesday it has completed construction of a new plant for coronavirus vaccines, doubling its capacity to more than 200 m...
S.Africa in talks with India's Macleods to set up HIV drug maker
CAPE TOWN, June 30 (Reuters) - South Africa is in partnership talks with India’s Macleods Pharmaceuticals Ltd to set up a state-owned company to make and sell HIV drugs in the local market, ...
Gilead prices COVID-19 drug candidate remdesivir at $390/vial in U.S.
June 29 (Reuters) - Gilead Sciences Inc said on Monday it has priced its COVID-19 treatment candidate remdesivir at $390 per vial in the United States and other developed countries.
35
36
37
38
39
40
41
42
43
